Eberle J, Wagner M, MacNeil S
Department of Dermatology, University Medical Centre Steglitz, The Free University of Berlin, Germany.
Pigment Cell Res. 1998 Jun;11(3):134-42. doi: 10.1111/j.1600-0749.1998.tb00723.x.
Several laboratories are pursuing the question of whether the expression of pigment genes can be used as a useful marker for tumour progression. However, many melanoma tumours are amelanotic in vivo. The purpose of this study was to examine the relationship between the expression of tyrosinase-related genes [tyrosinase, tyrosinase-related protein-1 (TRP-1) and tyrosinase-related protein-2 (TRP-2)] and pigmentation of melanoma cells. Fourteen cutaneous melanoma cell lines were examined for visible pigment, melanin content, and dopa oxidase activity and findings were related to the previously determined expression of the three tyrosinase-related genes in these cells in culture. Four of the cell lines were also stimulated with alpha-MSH, isobutylmethylxanthine, and forskolin to examine the relationship between induced pigmentation and upregulation of pigmentation genes. There was no simple correlation between pigmentation gene expression and dopa oxidase activity or total melanin content of the 14 melanoma cell lines in culture. In the majority of cells, there was no appreciable pigment, whereas, in contrast, half of the cells showed significant dopa oxidase activity. Upregulation of dopa oxidase activity was achieved by alpha-MSH in two out of four cell lines examined in detail and with IBMX in three out of four of these cell lines. IBMX increased tyrosinase gene expression in all four cell lines; alpha-MSH was without effect; and TRP-1 and TRP-2 expression were largely unaffected by IBMX or alpha-MSH. Modest changes in morphology were noted in response to IBMX. Overall, however, human melanoma cell lines were, with two exceptions, amelanotic in culture despite the fact that 10 out of the 14 lines expressed tyrosinase-related genes. We conclude that measurable pigmentation is not a necessary consequence of the expression of pigmentation genes. An implication of this work is that amelanotic tumours in vivo may nevertheless be positive for tyrosinase-related genes.
多个实验室正在研究色素基因的表达是否可作为肿瘤进展的有用标志物这一问题。然而,许多黑色素瘤肿瘤在体内是无色素的。本研究的目的是探讨酪氨酸酶相关基因[酪氨酸酶、酪氨酸酶相关蛋白-1(TRP-1)和酪氨酸酶相关蛋白-2(TRP-2)]的表达与黑色素瘤细胞色素沉着之间的关系。检测了14种皮肤黑色素瘤细胞系的可见色素、黑色素含量和多巴氧化酶活性,并将结果与之前在培养的这些细胞中测定的三种酪氨酸酶相关基因的表达情况相关联。还使用α-促黑素(α-MSH)、异丁基甲基黄嘌呤(IBMX)和福斯高林刺激其中4种细胞系,以研究诱导色素沉着与色素沉着基因上调之间的关系。培养的14种黑色素瘤细胞系中,色素沉着基因表达与多巴氧化酶活性或总黑色素含量之间没有简单的相关性。在大多数细胞中,没有明显的色素,而相反,一半的细胞显示出显著的多巴氧化酶活性。在详细检测的4种细胞系中,α-MSH使其中2种细胞系的多巴氧化酶活性上调,IBMX使其中3种细胞系的多巴氧化酶活性上调。IBMX使所有4种细胞系中的酪氨酸酶基因表达增加;α-MSH无作用;TRP-1和TRP-2的表达在很大程度上不受IBMX或α-MSH的影响。观察到对IBMX有适度的形态学变化。然而,总体而言,尽管14种细胞系中有10种表达酪氨酸酶相关基因,但人类黑色素瘤细胞系在培养中除了2种例外均为无色素的。我们得出结论,可测量的色素沉着不是色素沉着基因表达的必然结果。这项工作的一个启示是,体内无色素的肿瘤可能仍然酪氨酸酶相关基因为阳性。